the drug was developed by the british pharmaceutical giant astra zeneca with the original aim of treating certain types of tumour , but was shelved after it proved ineffective .
scientists at yale university in connecticut have revealed how the treatment , called azdo5030 , restored memory in mice given alzheimer 's disease .
an experimental cancer drug axed over poor results may have the ability to reverse the effects of alzheimer 's .